Aventis Behring Defies Competitive Pressure By Refusing To Distribute Products Direct to Patients

13-Nov-2000

King of Prussia, November 9, 2000 -Aventis Behring L.L.C. today launched Aventis Behring Choice, a national initiative designed to redirect the emerging competitive landscape - from managing product supply and distribution for people who live with chronic bleeding disorders - to one which more fully considers the spectrum of product, educational and resource needs of patients and healthcare professionals. Unveiled at the annual meeting of the National hemophilia Foundation, AB Choice programs are fully available to the entire bleeding disorders community, regardless of product prescribed, provider choice or patient insurance status - a bold contrast to some of the more restricted initiatives recently launched. "As an organization, we felt it was critical to remove ourselves from the pressures of the competitive environment as much as possible. Instead, we had extensive internal discussions about how to meet our corporate objectives, one which has always included respecting the voice of the bleeding disorders community," said Alain Delongchamp, Vice President, General Manager North America. "Once we accomplished this, the premise of AB Choice was born - we determined that the best way to support the care provided by hemophilia treatment centers was to recognize what healthcare professionals recognize everyday: each patient is unique." AB Choice: Customized services for the Entire Community Aventis Behring Choice is the only healthcare initiative in the nation designed to provide customized access to resources and educational services for members of the bleeding disorders community, regardless of product prescribed, provider distribution method or insurance status. The four pillars that form the foundation of AB Choice have been created with one goal in mind: to enhance and strengthen the partnership between patients and the healthcare professionals who treat them by providing meaningful services that improve quality of life. The pillars of AB Choice include: 1.Open Distribution. Patients using Aventis Behring products can access them through Aventis Behring Choice providers (Aventis Behring is in the process of interviewing potential AB Choice providers), PHS centers, hospitals, or home care. Products are and will remain available to any provider patients are currently using. 2.Customized Support Services. A wide variety of patient support services, which will include quality of life grants, a secure on-line community, and individualized disease information. 3.Patient Ed

https://www.chemeurope.com/en/news/334/aventis-behring-defies-competitive-pressure-by-refusing-to-distribute-products-direct-to-patients.html